Parkway Life REIT (PLife REIT)

Parkway Life REIT kept at 'buy' by DBS on strong earnings visibility
SINGAPORE (Oct 26): DBS Group Research is maintaining Parkway Life REIT (PLife REIT) at “buy” given the REIT offers one of the strongest earnings visibility profiles among S-REITs, with a weighted average lease expiry of close to nine years. See: Parkway Life REIT declares 3Q DPU of 3.23 cents, down 4.1% on absence of one-off gain In a Friday report, lead analyst Rachel Tan believes ...
Parkway Life REIT posts 3.7% drop in 2Q DPU to 3.19 cents on absence of one-off gains
SINGAPORE (July 26): The manager of Parkway Life REIT (PLife REIT) declared a 2Q18 DPU of 3.19 cents, bringing 1H18 DPU to 6.36 cents, 3.6% lower than 6.60 cents in 1H17. 2Q18 DPU was 3.7% lower compared to 3.32 cents in 2Q17 due to the absence of one-off distribution of divestment gain, which was present in 2Q17. For 2Q18, total distributable income to unitholders fell 3.7% to $19.3 ...
Parkway Life REIT declares 1Q DPU of 3.17 cents, 3.4% lower than a year ago in absence of one-off distribution gain
SINGAPORE (Apr 30): The manager of Parkway Life REIT (PLife REIT) has declared a 1Q18 distribution per unit (DPU) of 3.17 cents, down 3.4% from its 1Q17 DPU of 3.28 cents due to the absence of a one-off distribution of divestment gain in the previous year. This translates to a 3.4% lower annualised DPU of 12.68 cents compared to 13.12 cents a year ago, as well as an annualised distribution ...
Parkway Life REIT acquires nursing facility in Japan for $17.8 mil in sale and leaseback deal
SINGAPORE (Feb 7): The manager of Parkway Life REIT (PLife REIT) is acquiring Konosu Nursing Home Kyoseien, a nursing rehabilitation facility in Japan, from operator Iryouhoujin Shadan Kouaikai for 1.5 billion yen ($17.8 million) under a sale and leaseback deal. The yield-accretive acquisition will be made at 7.4% below its valuation of JPY1.62 billion as at end 2017, and is expected to ...
Parkway Life REIT kept at 'buy' on strong earnings visibility
SINGAPORE (Jan 29): DBS is keepings its “buy” rating on Parkway Life Real Estate Investment Trust (PLife REIT) with an increased target price of $3.15. In a Monday report, analyst Rachel Tan says, “PLife REIT offers one of the strongest earnings visibility profiles among SREITs, with a weighted average lease expiry (WALE) of close to nine years.” On Friday, the REIT announced its ...
This SREIT has resilient earnings, a robust balance sheet and no immediate refinancing needs
SINGAPORE (April 26): CIMB expects Parkway Life REIT earnings to remain one of the most resilient in the SREIT space, with its deflation-protected Singapore revenue and long-term lease structure in Japan. In addition, it expects the remaining asset disposal gains of $3.95 million to be paid out in equal instalments over the next three quarters. With the terming out of its loans due in FY18, ...
Parkway Life REIT sees 9.6% rise in 1Q DPU to 3.3 cents
SINGAPORE (April 25): Parkway Life REIT’s (PLife REIT) manager today posted a distribution per unit (DPU) of 3.28 cents for the first quarter ended March 31, up 9.6% from the 2.99 cents declared a year ago. Gross revenue for the quarter remained comparable to that of the previous year at $26.9 million, in spite of the REIT’s divestment of four Japan nursing homes in Dec 2016. (See also: ...
Parkway Life REIT’s 3Q results set the stage for further growth
SINGAPORE (Oct 28): CIMB Securities is reiterating its “add” recommendation on Parkway Life REIT (PLife REIT) with an unchanged target price of $2.78 following its release of financial results for 3Q16. Although the healthcare REIT posted an 8.8% blower 3Q DPU of 3.06 cents compared to 3.36 a year ago, revenue grew 8.2% while net property income (NPI) increased 8% y-o-y.   (See ...